{"disease":{"id":"atherosclerotic-cardiovascular-disease-ascvd","name":"atherosclerotic cardiovascular disease ascvd"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07141914","title":"A Master Protocol for Semaglutide Effects on Cardiovascular and Obesity-related Outcomes in People With Overweight or Obesity in the Real World","phase":"","overall_status":"COMPLETED","enrollment_count":285327,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT06874751","title":"Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity in the Real World","phase":"","overall_status":"COMPLETED","enrollment_count":45456,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT07196280","title":"Protective Effect of 5-Alpha Reductase Inhibitors on Atherosclerotic Cardiovascular Disease in Populations With BPH: Evidence From UK Biobank Cohort and Chinese Single Center Database Studies","phase":"","overall_status":"COMPLETED","enrollment_count":10000,"lead_sponsor_name":"Chinese PLA General Hospital","has_results":false},{"nct_id":"NCT06589791","title":"A Disease Area Study on the Awareness and Perceptions of Systemic Inflammation and hsCRP as a biomARKer in Patients With ASCVD and CKD in China Among Cardiologists and Nephrologists","phase":"","overall_status":"COMPLETED","enrollment_count":1500,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT07208331","title":"Evaluation of an Integrated, Digital, Nurse-led, Remote Monitoring Care Pathway for Cardiovascular Risk Management","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":750,"lead_sponsor_name":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","has_results":false},{"nct_id":"NCT05755373","title":"A Multinational Survey-based Study to Understand the Real-world Awareness and Perceptions of Systemic inFLAMmation and rolE of hsCRP as a Biomarker in Patients With AtheroSclerotic CardioVascular Disease and Chronic Kidney Disease Among Cardiologists","phase":"","overall_status":"COMPLETED","enrollment_count":602,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT06960902","title":"Study of the Determinants of Coronary Atherosclerosis in Familial Hypercholesterolemia (ATHERO-FH Study)","phase":"NA","overall_status":"RECRUITING","enrollment_count":600,"lead_sponsor_name":"Nantes University Hospital","has_results":false},{"nct_id":"NCT06813911","title":"Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":340,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT06322641","title":"A Study to Understand the Real-world Awareness and Perceptions of Systemic inFLAMmation and rolE of hsCRP as a Biomarker in Patients With AtheroSclerotic CardioVascular Disease and Chronic Kidney Disease Among Nephrologists","phase":"","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT07315997","title":"The Coronary Artery Calcium and Troponins in Rheumatoid Arthritis (CAT-RA) Study","phase":"","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":false},{"nct_id":"NCT05091073","title":"A Research Study Looking at the Effect of Food Intake on How the Medicine NN0385-0434 Behaves in the Body of Healthy Participants","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":73,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT07311330","title":"Phase IIa Clinical Trial of YN001 in Patients With Atherosclerotic Cardiovascular and Cerebrovascular Diseases and Erectile Dysfunction","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":40,"lead_sponsor_name":"Beijing Inno Medicine Co., Ltd.","has_results":false},{"nct_id":"NCT05834673","title":"VICTORION-ASCERTAIN: Implementation Study (v-ASCERTAIN)","phase":"NA","overall_status":"TERMINATED","enrollment_count":6,"lead_sponsor_name":"Monash University","has_results":false},{"nct_id":"NCT07000695","title":"Managed Access Programs for TQJ230, Pelacarsen","phase":"","overall_status":"AVAILABLE","enrollment_count":null,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false}],"total":14},"guidelines":[],"source":"Drug Landscape verified database"}